1.
Lancet Neurol
; 21(8): 671, 2022 08.
Article
in English
| MEDLINE | ID: covidwho-1931215
2.
Lancet Neurol
; 21(3): 203, 2022 03.
Article
in English
| MEDLINE | ID: covidwho-1692751
3.
Lancet Neurol
; 20(9): 685, 2021 09.
Article
in English
| MEDLINE | ID: covidwho-1364532
4.
Lancet Neurol
; 20(1): 1, 2021 01.
Article
in English
| MEDLINE | ID: covidwho-978051
Subject(s)
Alzheimer Disease/drug therapy , Amyloid beta-Peptides/immunology , Antibodies, Monoclonal, Humanized/pharmacology , Biomedical Research/standards , Clinical Trials as Topic/standards , Drug Approval , Research Design/standards , Antibodies, Monoclonal, Humanized/administration & dosage , Antibodies, Monoclonal, Humanized/adverse effects , Drug Approval/legislation & jurisprudence , Humans
5.
Lancet Neurol
; 20(4): 247, 2021 04.
Article
in English
| MEDLINE | ID: covidwho-1139638
6.
Lancet Neurol
; 19(5): 369, 2020 05.
Article
in English
| MEDLINE | ID: covidwho-1017025
7.
Lancet Neurol
; 19(11): 879, 2020 11.
Article
in English
| MEDLINE | ID: covidwho-885479
8.
Lancet Neurol
; 19(7): 557, 2020 07.
Article
in English
| MEDLINE | ID: covidwho-601598
Subject(s)
Betacoronavirus , Congresses as Topic/trends , Coronavirus Infections/epidemiology , Creativity , Neurology/trends , Pneumonia, Viral/epidemiology , COVID-19 , Clinical Trials as Topic/methods , Coronavirus Infections/therapy , Europe/epidemiology , Humans , Neurology/methods , Pandemics , Pneumonia, Viral/therapy , SARS-CoV-2
9.
Lancet Neurol
; 19(6): 471, 2020 06.
Article
in English
| MEDLINE | ID: covidwho-378002